TMO — Thermo Fisher Scientific
Data coverage, completeness and provenance for Thermo Fisher Scientific in the Stock Market API — Health Care · Diagnostics & Research.
Stored price coverage
Source date: 2026-11-19T21:00:02. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-11-19 | 688.7500 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-18 | 692.7400 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-17 | 686.7900 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-16 | 691.3300 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-13 | 700.2200 | USD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/TMO/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Profile
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Employees: 125,000 · Website: https://www.thermofisher.com · Profile fields populated: 75%
Data completeness by statement
Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/TMO/financials.
Financial statement coverage (USD)
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (USD) | 2025-12-31 | 31 | sec_edgar | ||||
| FY2024 (USD) | 2024-12-31 | 31 | sec_edgar | ||||
| FY2023 (USD) | 2023-12-31 | 31 | sec_edgar | ||||
| FY2022 (USD) | 2022-12-31 | 30 | sec_edgar | ||||
| FY2021 (USD) | 2021-12-31 | 30 | sec_edgar |
Get TMO data via the API
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Company profile
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/TMO
Financial statements
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/TMO/financials
Computed ratios
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/TMO/metrics/summary
News & announcements
Dated press releases and announcements with source links.
GET /api/v1/companies/TMO/news
Quick start
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/TMO
Query TMO programmatically
Free tier — instant API key. Built for AI agents.
Other NYSE · Health Care companies covered
Frequently Asked Questions
- What data does the API provide for TMO?
- Stored coverage for TMO: price data available, financial statements available, 0 archived filings. REST endpoints are under /api/v1/companies/TMO; inspect available source metadata for provenance.
- How complete is TMO's financial data?
- The anchor reporting period (FY2025) has 88.2% of the 17 core statement fields populated. Primary source: sec_edgar.
- What reporting periods are covered for TMO?
- 5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/TMO/financials.
- Where does TMO's data come from?
- Stored price source: yfinance. Primary source for the statement snapshot: sec_edgar. Inspect available period and field source tags at /api/v1/companies/TMO/financials; missing tags do not establish provenance.